Ben-Gurion University of the Negev
35 articles with Ben-Gurion University of the Negev
The system, based on machine learning algorithms for analyzing EEG signals, can predict upcoming seizures up to an hour prior to onset NeuroHelp, a newly founded startup that licensed and is developing the technology, is a portfolio company of Oazis accelerator, formed by the Yazamut360 entrepreneurship center of Ben-Gurion University
Yazamut360 Entrepreneurship Center of Ben-Gurion University Launches Oazis Accelerator to Promote New Technologies Originating from the University
Oazis to hold a virtual demo day on September 15 showcasing groundbreaking technologies of its six portfolio companies in the fields of health, advertising, sustainability and software
Scientists at Ben-Gurion University of the Negev Develop Anti-Coronavirus Surface Coating Based on Nanomaterials
The Technology received financial support from the Israel Innovation Authority as part of a call for proposals for coping with the coronavirus
BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, introduces a novel method developed by researchers at Ben-Gurion University for screening and detecting new antibiotics.
Researchers from Ben-Gurion University and Cincinnati Children's Introduce Technology for Removal of Secretions from Airways
Treatment of diseases affecting the respiratory tract, such as bronchiolitis, chronic obstructive pulmonary disease and cystic fibrosis was developed in the framework of the multi-year collaboration between BGU and Cincinnati Children's
ANANDA Scientific Forms Research Collaboration and License Agreement with Ben-Gurion University for Cannabinoid Products for Topical Applications
The research will focus on nanotechnology based CBD- products for the treatment of psoriasis and other diseases
Novel non-dexterous, end-effector for automated production lines has the ability to grasp multiple shapes
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
BGN Technologies announced that it has entered into an exclusive worldwide license agreement with Vaxil Bio for the development and commercialization of targeted cancer therapy.
Ben-Gurion University Introduces Superior Forensic Blood Detection Test Using Luminescence-Based Detection
BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, introduces a new chip device that offers superior identification of miniscule blood residues for forensic applications.
New Therapy For Atherosclerosis Developed By Ben-Gurion University of the Negev And Sheba Medical Center Researchers
Ben-Gurion University of the Negev Researchers Identify Child Pedestrian Behaviors That Promote Accidents
It's Official: A Glass Of Red Wine With Dinner Can Improve Heart Health In Diabetics, According To Ben-Gurion University of the Negev Researchers
Sorrento Therapeutics, Inc. and Ben-Gurion University of the Negev Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
Cincinnati Children's Hospital Medical Center-Ben-Gurion University of the Negev Collaboration Developing Kid-Sized Medical Devices